Schoeneck James A
- SEC CIK
- 0001420987
No open-market purchases or sales filed in the past year.
Current role at each company
- CLDI Calidi Biotherapeutics, Inc.Directoras of Aug 19, 2026
- KYNB Kyntra Bio, Inc.Directoras of Jun 17, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Schoeneck James A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CLDI Calidi Biotherapeutics, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2025 (view filing) | Aug 21 | 4 days | Schoeneck James ADirector | PPurchase | +75.0K | $2.00 | +$150.0K | +6,613.8%76.1K after | |
| Aug 25, 2025 (view filing) | Aug 21 | 4 days | Schoeneck James ADirector | PPurchase | +75.0K | – | – | –75.0K after | Derivative |
KYNB Kyntra Bio, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2025 (view filing) | Jun 30 | 2 days | Schoeneck James ADirector | PPurchase | +23.6K | $5.07 | +$119.5K | +146.4%39.7K after | |
| Mar 24, 2025 (view filing)9:00 AM ET | Mar 20-21 | 4 days | Schoeneck James ADirector | PPurchase | +300.0K | $0.3501 | +$105.0K | +406.9%373.7K after | 2 lots |
| Jun 9, 2023 (view filing) | Jun 7 | 2 days | Schoeneck James ADirector | SSale | −7.10K | $18.03 | −$128.0K | −8.8%73.7K after | 10b5-1 |